GH vs Peers Stock Comparison

Guardant Health Prices as of Oct 26, 2026 Peers: Industry group
GH Guardant Health, Inc.
$173.25 -2.3% 1M +140.1% 1Y
Market cap
$23.15B
P/E
–
Revenue (TTM)
$1.18B
Div. yield
–
Diagnostic Labs Healthcare

Percentile Scorecard

GH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisGH
Valuation 30 #20 of 28
Growth 35 #16 of 24
Profitability 5 #21 of 22
Financial Health 59 #15 of 35
Shareholder Returns 0 #11 of 11
Overall 26
  • GH ranked among 36 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodGHSPY
1 month -2.3% -0.8%
3 months +19.1% +3.5%
6 months +95.8% +7.0%
Year to date +69.6% +12.2%
1 year +140.1% +13.0%
3 years +594.1% +86.3%
3 years, per year +90.8% +23.1%
5 years +54.3% +68.6%
5 years, per year +9.1% +11.0%

Risk

MeasureGHSPY
Volatility, 1Y 57.4% 12.7%
Downside volatility, 1Y 48.7% 12.7%
Beta vs S&P 500, 1Y 1.02 1.00
Return / volatility, 1Y 2.44 1.02
Max drawdown, 5Y -86.7% -25.4%
From 52-week high -7.5% -1.8%
52-week high $187.22 $779.14
52-week low $69.58 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleGH
P/E now vs peer median -50.8xmedian 17.7x
P/S now vs peer median 19.6xmedian 1.3x
EV/EBITDA now vs peer median -51.2xmedian 17.4x
P/FCF now vs peer median -96.2xmedian 24.8x
P/B now vs peer median -103.9xmedian 2.7x
PEG now vs peer median -5.11median 0.58

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsGH
Revenue $1.18B
Gross profit $769.16M
Operating income -$470.26M
Net income -$453.44M
Free cash flow -$240.72M
R&D $375.79M
EPS (diluted) $-3.41
Cash & equivalents $1.05B
Shares (diluted) 132.87M
Enterprise value $19.21B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricGH
P/E -50.8x
P/FCF -96.2x
P/Operating cash flow -125.0x
P/S 19.6x
P/B -103.9x
P/Tangible book -93.3x
EV/EBITDA -51.2x
EV/EBIT -47.0x
EV/Revenue 18.7x
EV/FCF -91.8x
EV/Operating cash flow -119.3x
PEG (3Y EPS CAGR) -5.11

Growth

14 metrics
MetricGH
Revenue growth (1Y) 42.7%
Revenue CAGR (3Y) 32.4%
Gross profit growth (1Y) 47.7%
Gross profit CAGR (3Y) –
Operating income growth (1Y) -2.1%
Operating income CAGR (3Y) 4.8%
Net income growth (1Y) -9.6%
Net income CAGR (3Y) 3.7%
EPS growth (1Y) -2.4%
EPS CAGR (3Y) 9.9%
Operating cash flow growth (1Y) 22.4%
Operating cash flow CAGR (3Y) 18.1%
Free cash flow growth (1Y) 11.4%
Free cash flow CAGR (3Y) 14.4%

Profitability

14 metrics
MetricGH
Gross margin 65.0%
EBITDA margin -36.5%
Operating margin -39.7%
Pretax margin -38.4%
Net margin -38.3%
FCF margin -20.3%
Operating cash flow margin -15.7%
Return on equity –
Return on assets -23.7%
Return on invested capital –
Return on capital employed -29.9%
Asset turnover 0.6x
Cash conversion (OCF / net income) 0.4x
Stock comp / revenue 16.2%

Financial Health

11 metrics
MetricGH
Debt / assets –
Debt / equity –
Net debt / EBITDA –
Debt / FCF –
Liabilities / assets 111.7%
Equity / assets -11.7%
Interest coverage -97.6x
Current ratio 4.0x
Quick ratio 3.5x
Cash ratio 3.1x
Altman Z-score 4.59

Shareholder Returns

7 metrics
MetricGH
Dividend yield –
Net buyback yield -1.7%
Shareholder yield -1.7%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusGH
EPS, next fiscal year $-3.34FY2026
Revenue, next fiscal year $1.42BFY2026
Revenue growth, next FY +44.5%FY2026
Revenue growth, the year after +27.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersGH
Held by institutions 100.0%
Institutions holding 594
Change in shares held, QoQ -2.6%
Institutions buying 353
Institutions selling 180
Buyers to sellers 1.96

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.